The Giant Awakens - Law and Economics of Excessive Pricing & COVID-19 Crisis

B. Kianzad
{"title":"The Giant Awakens - Law and Economics of Excessive Pricing & COVID-19 Crisis","authors":"B. Kianzad","doi":"10.2139/SSRN.3706793","DOIUrl":null,"url":null,"abstract":"The COVID-19 crisis have once again elevated one of the most contentious themes in competition law and economics, namely how to deal with excessive pricing and price gouging, to the global stage. Dramatic, sudden price hikes on essential medicines and medical supplies (a practice known as price gouging, or excessive pricing) are reported in many countries affected by the crisis. The Competition Authorities have received many complaints in regards to excessive pricing / price gouging and some have already started investigations, others are closely monitoring the developments. Like a mythical giant, dormant but defiant, excessive pricing time and again captures the attention of policymakers, competition law practitioners and scholars, despite its demise being proclaimed as frequently by a certain strand of law and economics. Excessive Pricing and Price Gouging belong to the most written about, and least understood, issues in competition law and economics, with significantly conflicting views depending on the normative departing points regarding theories of harm, scope and object of competition law and legal-philosophical perspectives. Where one side of the axis elevates presumptions of supposed virtues of excessive prices, self-correcting markets and possible chilling effects on costly and risky innovation in face of vigilant enforcement, the other side of the axis point to wealth transfers as being the prima facie competition law concern, the errors in presumptions by the antagonists of enforcement and ultimately forwards the need to pursue competition law alongside fairness and social policy paradigm beyond a \"purist\" economic efficiency doctrine. The paper is structured as follows. Following the introductory section depicting excessive pricing theme in general, Section two revisits some examples of excessive pricing and price gouging during the COVID-19 pandemic. Section three offers a critical overview of law and economics theory informing much of the scholarly debate on excessive pricing as an anti-competitive practice. Section four presents an updated overview of the origins of the prohibition as well as recent enforcement actions in European Competition Law, demonstrating a shifting ground. Section five critically approaches the various arguments pro and con excessive pricing enforcement in the literature, finding the bulk of the normative and empirical arguments against enforcement not particularly persuasive. Section six concludes with a view on and beyond COVID-19 crisis with some law and policy recommendations.","PeriodicalId":401648,"journal":{"name":"European Public Law: EU eJournal","volume":"54 1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Public Law: EU eJournal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2139/SSRN.3706793","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The COVID-19 crisis have once again elevated one of the most contentious themes in competition law and economics, namely how to deal with excessive pricing and price gouging, to the global stage. Dramatic, sudden price hikes on essential medicines and medical supplies (a practice known as price gouging, or excessive pricing) are reported in many countries affected by the crisis. The Competition Authorities have received many complaints in regards to excessive pricing / price gouging and some have already started investigations, others are closely monitoring the developments. Like a mythical giant, dormant but defiant, excessive pricing time and again captures the attention of policymakers, competition law practitioners and scholars, despite its demise being proclaimed as frequently by a certain strand of law and economics. Excessive Pricing and Price Gouging belong to the most written about, and least understood, issues in competition law and economics, with significantly conflicting views depending on the normative departing points regarding theories of harm, scope and object of competition law and legal-philosophical perspectives. Where one side of the axis elevates presumptions of supposed virtues of excessive prices, self-correcting markets and possible chilling effects on costly and risky innovation in face of vigilant enforcement, the other side of the axis point to wealth transfers as being the prima facie competition law concern, the errors in presumptions by the antagonists of enforcement and ultimately forwards the need to pursue competition law alongside fairness and social policy paradigm beyond a "purist" economic efficiency doctrine. The paper is structured as follows. Following the introductory section depicting excessive pricing theme in general, Section two revisits some examples of excessive pricing and price gouging during the COVID-19 pandemic. Section three offers a critical overview of law and economics theory informing much of the scholarly debate on excessive pricing as an anti-competitive practice. Section four presents an updated overview of the origins of the prohibition as well as recent enforcement actions in European Competition Law, demonstrating a shifting ground. Section five critically approaches the various arguments pro and con excessive pricing enforcement in the literature, finding the bulk of the normative and empirical arguments against enforcement not particularly persuasive. Section six concludes with a view on and beyond COVID-19 crisis with some law and policy recommendations.
巨人觉醒:定价过高和COVID-19危机的法律和经济学
新冠肺炎疫情再次将竞争法和经济学中最具争议的主题之一——如何应对过度定价和价格欺诈——推上了全球舞台。据报告,在许多受危机影响的国家,基本药物和医疗用品价格突然大幅上涨(一种被称为哄抬价格或定价过高的做法)。竞争事务主管当局已接获许多有关定价过高/哄抬价格的投诉,有些已展开调查,有些则正密切监察事态发展。过度定价就像一个神话般的巨人,蛰伏着,但却充满挑战,它一次又一次地吸引着政策制定者、竞争法从业者和学者的注意,尽管某些法律和经济学分支经常宣布它的消亡。过度定价和价格欺诈是竞争法和经济学中被写得最多、但理解得最少的问题,它们的观点相互矛盾,这取决于关于损害、竞争法的范围和对象以及法律哲学观点的规范性出发点。轴心的一边认为,面对警惕的执法,过高的价格、自我纠正的市场以及对成本高、风险大的创新可能产生的寒蝉效应是有好处的,而轴心的另一边则指出,财富转移是竞争法的首要关切。执法对手在假设上的错误,最终提出了在“纯粹主义”经济效率学说之外,追求竞争法与公平和社会政策范式的必要性。本文的结构如下。在介绍定价过高主题之后,第二节回顾了2019冠状病毒病大流行期间定价过高和哄抬价格的一些例子。第三节提供了法律和经济学理论的批判性概述,为过度定价作为反竞争实践的学术辩论提供了信息。第四节介绍了禁令起源的最新概述,以及欧洲竞争法中最近的执法行动,展示了一个不断变化的基础。第五节批判性地探讨了文献中支持和反对过度定价执行的各种论点,发现反对执行的大部分规范和经验论点不是特别有说服力。第六部分总结了对COVID-19危机的看法,并提出了一些法律和政策建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信